Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000894763 | SCV001038769 | likely benign | not provided | 2019-12-31 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000894763 | SCV004159431 | likely benign | not provided | 2024-01-01 | criteria provided, single submitter | clinical testing | CSMD1: BS2 |
Breakthrough Genomics, |
RCV000894763 | SCV005220474 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Vavilov Institute of General Genetics RAS, |
RCV002051903 | SCV002099778 | pathogenic | Cerebellar ataxia | no assertion criteria provided | research | ||
Prevention |
RCV003922837 | SCV004740439 | benign | CSMD1-related disorder | 2019-05-24 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |